is mounjaro a glp-1 medicine Eli Lilly launches weight loss drug in India at Rs 3,500 per 2.5mg dose Stroke: GLP-1s Like Ozempic, Mounjaro

doi: 10.1210/clinem/dgab103

How significant is the growth outlook for the USA in this market

Dont Have Diabetes Diagnosis The Problem: Mounjaro only covered for type 2 diabetes Want tirzepatide for weight loss only Dont qualify for Mounjaro coverage Zepbound not covered either The Solution: Alternatives dont require diabetes diagnosis and focus on weight loss indication

Something about the newer, more potent formulations, or perhaps the degree of weight loss they produce, drives the risk higher

The regulatory requirements for biosimilar approval are considerably more demanding than for small-molecule ANDAs

This drug has recently been approved by the U.S